RuiZhouBio Biotechnology Co., Ltd announced that it will receive CNY 290 million on December 12, 2017. The transaction will include participation from Changchun High & New Technology Industry (Group) Inc. (SZSE:000661) for gross proceeds of CNY 232 million to acquire 40% stake and Changchun BCHT Biotechnology Co. Ltd for gross proceeds of CNY 58 million to acquire 10% stake. Out of the total, CNY 10 million will go to registered capital. Post the closing, the registered capital will increase from CNY 10 million to CNY 20 million. The company signed investment agreement with the investors. The transaction has been approved in the 28th meeting of 8th Directorate by Changchun High & New Technology Industry (Group) Inc. The transaction does not need shareholder approval.